Subscribe
type here...
Subscribe
HomeInsightsExpert Opinion

Expert Opinion

Opinion pieces and editorials from industry leaders and experts on the key challenges, regulations, and future of the pharmaceutical and biotech sectors.

Partner Posts

GMP-inspections of veterinary manufacturers in the second half of 2021

Techno -
The review provides information related to the inspection of manufacturers of medicinal products for veterinary use for compliance with the requirements of the Good Manufacturing Practice (GMP).
Partner Posts

What veterinary medicines manufacturers ask about?

Techno -
On September 22-24, the VI All Russia GMP Conference with international participation, organized by the Ministry of Industry and Trade of Russia together with...
Expert Opinion

Do I still need the vaccine if I have COVID-19?

Techno -
Even if you've had COVID infection, that you should go ahead and take the vaccination when it's available to you.
EAEU Market

Top biopharma companies could be affected by Brazilian drug patent suspension

Techno -
GlaxoSmithKline will be the most affected, as it represents 26% of the potentially impacted drugs. This is followed by Novartis at 14%, Sanofi at 11%, and both Pfizer and Bayer with 8%.
EAEU Market

Contract production of pharmaceutical ingredients by 2028 may reach $ 136 billion

Techno -
The traditional active pharmaceutical ingredient dominated the market and accounted for the largest revenue share of 40.5% in 2020.
AI in Pharma

AI and big data will continue to disrupt pharmaceutical sector

Techno -
AI and big data have been identified by healthcare industry professionals as the top technologies that will transform pharmaceutical drug discovery and development processes.
1...3456Page 4 of 6
spot_img

Latest News

spot_img

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

Headlines

Obesity Pill Battle: Lilly’s Chemistry vs. Novo’s Peptides

0
2026 marks not just the arrival of new therapies,...

OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform

0
OpenAI has officially announced its expansion into the healthcare...

FEFU to Launch Russia’s First University-Based GMP Site for Biologics

0
Far Eastern Federal University (FEFU) has announced plans to establish a comprehensive infrastructure for the development and commercialization of biotech products.

FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy

0
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.

Newsletter

Get important news delivered directly to your inbox and stay connected!

© PHARMPROM 2026